Mylan's insulin glargine
Sponsors
Mylan Inc.
Conditions
Type 1 DiabetesType 1 Diabetes MellitusType 2 Diabetes
Phase 3
Non-inferiority Study to Compare the Efficacy and Safety of Mylan's Insulin Glargine With Lantus® in Type 2 Diabetes Mellitus Patients (INSTRIDE 2)
CompletedNCT02227875
Start: 2014-08-31End: 2015-12-31Updated: 2022-03-03
Non-inferiority Study to Compare the Efficacy and Safety of Mylan's Insulin Glargine With Lantus® in Type 1 Diabetes Mellitus Patients (INSTRIDE 1)
CompletedNCT02227862
Start: 2014-06-30End: 2016-07-31Updated: 2022-03-03
Extension Study to Assess Safety and Efficacy of Mylan's Insulin Glargine and Lantus® in Type 1 Diabetes Mellitus (T1DM) Patients
CompletedNCT02666430
Start: 2015-12-31End: 2017-07-31Updated: 2022-03-03